Subscribe to our newsletter

Inflammatory Bowel Disease Registry

CorEvitas is now part of Thermo Fisher Scientific. Read More.
+
STUDY VISITS
+
PATIENTS
+
GASTROENTEROLOGISTS

Outcome measures in the CorEvitas IBD Registry.

Among the variables we collect, some of the key outcome measures to inform your research include:

Clinician Reported Outcomes

Calculated Measures

Patient Reported Outcomes

Registry Scientific Advisors

Joshua Korzenik, MD

Joshua Korzenik, MD

Director, Crohn’s and Colitis Center, Division of Gastroenterology, Hepatology and Endoscopy, Brigham & Women’s Hospital | Assistant Professor, Harvard Medical School | CorEvitas IBD Registry Scientific Co-Director and Scientific Advisory Committee Chair

Ray Cross, MD, MS, AGAF, FACG

Ray Cross, MD, MS, AGAF, FACG

Director of the IBD Program, University of Maryland School of Medicine | Co-Director, Digestive Health Center | Professor of Medicine, Division of Gastroenterology and Hepatology, University of Maryland I CorEvitas IBD Registry Scientific Co-Director and Scientific Advisory Committee Chair

Scientific Advisory Committee

  • Jenny Sauk , UCLA
  • Doug Wolf , Atlanta Gastroenterology Associates
  • Bincy Abraham, Houston Methodist
  • Sara Horst, Vanderbilt Digestive Disease Center
  • Syan Stidham, University of Michigan
  • David Hudesman, NYU Langone Medical Center
  • Gursimran Kochhar, Allegheny General Hospital
  • Parakkal Deepak, Washington University in St. Louis